Six African countries, including Tunisia, have been chosen to accommodate their own production of Messenger RNA vaccines (mRNA), as the first beneficiaries of the World Health Organization (WHO) for the production of these vaccines, she announced.
South Africa, Egypt, Kenya, Nigeria, Senegal and Tunisia have been chosen by WHO to allow the African continent, which has had limited access to anti-Cavid vaccines, to manufacture its own anti-Cavid and others.
The announcement of the transfer of mRNA technology is to take place this Friday, February 18, 2022 in Brussels on Friday, February 18, 2022 during a ceremony on the sidelines of the summit between the European Union and the African Union.
Before the production of vaccines, the WHO will develop, with the first six chosen countries, a roadmap in terms of training and support.
The new productions in Africa, first of all intended to combat the COVVI-19, will be able to manufacture other vaccines and products.
